Working... Menu

Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02406651
Recruitment Status : Active, not recruiting
First Posted : April 2, 2015
Last Update Posted : June 3, 2019
Memorial Sloan Kettering Cancer Center
Information provided by (Responsible Party):
Generon (Shanghai) Corporation Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : April 9, 2019
  Estimated Study Completion Date : March 8, 2020